言語を選択

CD59

CD59 詳細

英語名	CD59 glycoprotein	市販薬剤の数	0
治験薬の数	1	ターゲットの別称	CD59 Antigens，Membrane attack complex inhibition factor，Membrane inhibitor of reactive lysis，MEM43 antigen，HRF-20，MIRL，20 kDa homologous restriction factor，MAC-inhibitory protein，MACIF，Protectin，MAC-IP，1F5 antigen，P18-20，CD59 Molecule， Complement Regulatory Protein，MSK21，CD59 Antigen， Complement Regulatory Protein，16.3A5，Lymphocytic Antigen CD59/MEM43，MIC11，MIN1，Ly-6-Like Protein，1F5，T Cell-Activating Protein，CD59 Antigen，EJ30，MIN2，MIN3，EL32，Surface Anitgen Recognized By Monoclonal Antibody 16.3A5，MEM43，EJ16，G344，CD59 Molecule (CD59 Blood Group)，Membrane Attack Complex (MAC) Inhibition Factor，CD59 Molecule，CD59 Antigen P18-20 (Antigen Identified By Monoclonal Antibodies 16.3A5， EJ16， EJ30， EL32 And G344)，Human Leukocyte Antigen MIC11，HRF20，CD59 Blood Group Antigen
研究＆開発段階	Phase 2 Clinical

英語名	CD59 glycoprotein
ターゲットの別称	CD59 Antigens，Membrane attack complex inhibition factor，Membrane inhibitor of reactive lysis，MEM43 antigen，HRF-20，MIRL，20 kDa homologous restriction factor，MAC-inhibitory protein，MACIF，Protectin，MAC-IP，1F5 antigen，P18-20，CD59 Molecule， Complement Regulatory Protein，MSK21，CD59 Antigen， Complement Regulatory Protein，16.3A5，Lymphocytic Antigen CD59/MEM43，MIC11，MIN1，Ly-6-Like Protein，1F5，T Cell-Activating Protein，CD59 Antigen，EJ30，MIN2，MIN3，EL32，Surface Anitgen Recognized By Monoclonal Antibody 16.3A5，MEM43，EJ16，G344，CD59 Molecule (CD59 Blood Group)，Membrane Attack Complex (MAC) Inhibition Factor，CD59 Molecule，CD59 Antigen P18-20 (Antigen Identified By Monoclonal Antibodies 16.3A5， EJ16， EJ30， EL32 And G344)，Human Leukocyte Antigen MIC11，HRF20，CD59 Blood Group Antigen
市販薬剤の数	0
治験薬の数	1
研究＆開発段階	Phase 2 Clinical

CD59 製品リスト

属性
Protein (2)
製品ライブラリ
オンライン (2)
種
Human (2)
タグ
His Tag (1)His Tag & Avi Tag (1)
マーカー
Unconjugated (1)Biotin-labeled (1)

製品番号	種	発現システム	製品説明	タンパク質の構造	純度	特性
CD9-H52H9	Human	HEK293	Human CD59 Protein, His Tag
CD9-H82E3	Human	HEK293	Biotinylated Human CD59 Protein, His,Avitag™

総数量2

CD59バックグランド

CD59, also known as membrane attack complex inhibition factor (MACIF), Protectin, 1F5 antigen, HRF-20 and MIRL. CD59 has been identified as a glycosylphosphatidylinositol-anchored membrane protein that acts as an inhibitor of the formation of the membrane attack complex to regulate complement activation. Potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. Involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase.

CD59分子の別称

CD59,16.3A5,1F5,EJ16,EJ30,EL32,FLJ38134,FLJ92039,G344,HRF20,MAC-IP,MACIF,MEM43,MGC2354,MIC11,MIN1,MIN2,MIN3,MIRL,MSK21,p18-20,Protectin

治験薬に関する情報

英語名	研究コード	研究開発ステージ	会社	適応症	臨床試験
Onzemipgene Parvec	HMR-59; AAVCAGsCD59; JNJ-81201887; JNJ-1887	Phase 2 Clinical	Tufts University	Geographic Atrophy; Macular Degeneration; Pyruvate kinase deficiency	詳細